Trade Names
Synonyms
Status
Molecule Category UNKNOWN
ATC N01AX07
UNII Z22628B598

Structure

InChI Key NPUKDXXFDDZOKR-LLVKDONJSA-N
Smiles CCOC(=O)c1cncn1[C@H](C)c1ccccc1
InChI
InChI=1S/C14H16N2O2/c1-3-18-14(17)13-9-15-10-16(13)11(2)12-7-5-4-6-8-12/h4-11H,3H2,1-2H3/t11-/m1/s1

Physicochemical Descriptors

Property Name Value
Molecular Formula C14H16N2O2
Molecular Weight 244.29
AlogP 2.67
Hydrogen Bond Acceptor 4.0
Hydrogen Bond Donor 0.0
Number of Rotational Bond 4.0
Polar Surface Area 44.12
Molecular species NEUTRAL
Aromatic Rings 2.0
Heavy Atoms 18.0

Bioactivity

Mechanism of Action Action Reference
GABA-A receptor; anion channel positive modulator POSITIVE MODULATOR PubMed PubMed
Protein: GABA-A receptor; anion channel

Description: Gamma-aminobutyric acid receptor subunit pi

Organism : Homo sapiens

O00591 ENSG00000094755
Protein: GABA-A receptor; anion channel

Description: Gamma-aminobutyric acid receptor subunit delta

Organism : Homo sapiens

O14764 ENSG00000187730
Protein: GABA-A receptor; anion channel

Description: Gamma-aminobutyric acid receptor subunit alpha-1

Organism : Homo sapiens

P14867 ENSG00000022355
Protein: GABA-A receptor; anion channel

Description: Gamma-aminobutyric acid receptor subunit beta-1

Organism : Homo sapiens

P18505 ENSG00000163288
Protein: GABA-A receptor; anion channel

Description: Gamma-aminobutyric acid receptor subunit gamma-2

Organism : Homo sapiens

P18507 ENSG00000113327
Protein: GABA-A receptor; anion channel

Description: Gamma-aminobutyric acid receptor subunit beta-3

Organism : Homo sapiens

P28472 ENSG00000166206
Protein: GABA-A receptor; anion channel

Description: Gamma-aminobutyric acid receptor subunit alpha-5

Organism : Homo sapiens

P31644 ENSG00000186297
Protein: GABA-A receptor; anion channel

Description: Gamma-aminobutyric acid receptor subunit alpha-3

Organism : Homo sapiens

P34903 ENSG00000011677
Protein: GABA-A receptor; anion channel

Description: Gamma-aminobutyric acid receptor subunit alpha-2

Organism : Homo sapiens

P47869 ENSG00000151834
Protein: GABA-A receptor; anion channel

Description: Gamma-aminobutyric acid receptor subunit beta-2

Organism : Homo sapiens

P47870 ENSG00000145864
Protein: GABA-A receptor; anion channel

Description: Gamma-aminobutyric acid receptor subunit alpha-4

Organism : Homo sapiens

P48169 ENSG00000109158
Protein: GABA-A receptor; anion channel

Description: Gamma-aminobutyric acid receptor subunit epsilon

Organism : Homo sapiens

P78334 ENSG00000102287
Protein: GABA-A receptor; anion channel

Description: Gamma-aminobutyric acid receptor subunit alpha-6

Organism : Homo sapiens

Q16445 ENSG00000145863
Protein: GABA-A receptor; anion channel

Description: Gamma-aminobutyric acid receptor subunit gamma-1

Organism : Homo sapiens

Q8N1C3 ENSG00000163285
Protein: GABA-A receptor; anion channel

Description: Gamma-aminobutyric acid receptor subunit gamma-3

Organism : Homo sapiens

Q99928 ENSG00000182256
Protein: GABA-A receptor; anion channel

Description: Gamma-aminobutyric acid receptor subunit theta

Organism : Homo sapiens

Q9UN88 ENSG00000268089
Assay Description Organism Bioactivity Reference
Inhibition of 5HT3 receptor at 2.3 uM Homo sapiens 11.0 %
Displacement of [131I]IMTO from CYP450c 11 in Wistar rat adrenal membrane Rattus norvegicus 1.08 nM
Inhibition on cortisol secretion in human NCI-H295 cells after 48 hrs Homo sapiens 4.57 nM
Inhibition of human CYP11B2 expressed in chinese hamster V79 cells Homo sapiens 1.7 nM
Inhibition of human CYP11B1 expressed in chinese hamster V79 cells Homo sapiens 0.5 nM
Inhibition of 5HT3A receptor expressed in Xenopus oocyte at 300 uM None 1.3 %
Inhibition of human CYP11B1 expressed in hamster V79MZ cells using 11-deoxycorticosterone substrate Homo sapiens 0.5 nM
Inhibition of human CYP11B2 expressed in hamster V79MZ cells using 11-deoxycorticosterone substrate Homo sapiens 0.1 nM
Inhibition of human CYP11B1 expressed in hamster V79 MZ cells using [3H] 11 deoxycorticosterone as substrate by HPLC radioflow detector Homo sapiens 0.5 nM
Inhibition of human CYP11B2 expressed in hamster V79 MZ cells using [3H] 11 deoxycorticosterone as substrate by HPLC radioflow detector Homo sapiens 0.1 nM
Inhibition of human aldosterone synthase expressed in V79 MZ cells pretreated with compound for 1 hr followed by addition of 500 nM 11-deoxycorticosterone for 1hr by HPLC analysis Homo sapiens 1.7 nM
Inhibition of human CYP11B1 expressed in V79 MZ cells pretreated with compound for 1 hr followed by addition of 500 nM 11-deoxycorticosterone for 3 hrs by HPLC analysis Homo sapiens 0.5 nM
Antibacterial activity against Staphylococcus aureus MRSA ATCC 43300 (CO-ADD:GP_020); MIC in CAMBH media, using NBS plates, by OD(600) Staphylococcus aureus subsp. aureus 11.17 %
Antibacterial activity against Escherichia coli ATCC 25922 (CO-ADD:GN_001); MIC in CAMBH media using NBS plates, by OD(600) Escherichia coli 2.26 %
Antibacterial activity against Klebsiella pneumoniae MDR ATCC 70063 (CO-ADD:GN_003); MIC in CAMBH media using NBS plates, by OD(600) Klebsiella pneumoniae 12.64 %
Antibacterial activity against Pseudomonas aeruginosa ATCC 27853 (CO-ADD:GN_042); MIC in CAMBH media using NBS plates, by OD(600) Pseudomonas aeruginosa 14.32 %
Antibacterial activity against Acinetobacter baumannii ATCC 19606 (CO-ADD:GN_034); MIC in CAMBH media using NBS plates, by OD600 Acinetobacter baumannii 8.53 %
Antifungal activity against Candida albicans ATCC 90028 (CO-ADD:FG_001); MIC in YNB media using NBS plates, by OD630 Candida albicans 0.03 %
Antifungal activity against Cryptococcus neoformans H99 ATCC 208821 (CO-ADD:FG_002); MIC in YNB media using NBS plates, by Resazurin OD(600-570) Cryptococcus neoformans 0.21 %
Antiviral activity determined as inhibition of SARS-CoV-2 induced cytotoxicity of Caco-2 cells at 10 uM after 48 hours by high content imaging Homo sapiens 4.52 %
SARS-CoV-2 3CL-Pro protease inhibition percentage at 20µM by FRET kind of response from peptide substrate Severe acute respiratory syndrome coronavirus 2 22.13 % SARS-CoV-2 3CL-Pro protease inhibition percentage at 20µM by FRET kind of response from peptide substrate Severe acute respiratory syndrome coronavirus 2 2.65 % SARS-CoV-2 3CL-Pro protease inhibition percentage at 20µM by FRET kind of response from peptide substrate Severe acute respiratory syndrome coronavirus 2 8.814 %
Antiviral activity determined as inhibition of SARS-CoV-2 induced cytotoxicity of VERO-6 cells at 10 uM after 48 hours exposure to 0.01 MOI SARS CoV-2 virus by high content imaging Chlorocebus sabaeus 0.14 % Antiviral activity determined as inhibition of SARS-CoV-2 induced cytotoxicity of VERO-6 cells at 10 uM after 48 hours exposure to 0.01 MOI SARS CoV-2 virus by high content imaging Chlorocebus sabaeus -0.07 % Antiviral activity determined as inhibition of SARS-CoV-2 induced cytotoxicity of VERO-6 cells at 10 uM after 48 hours exposure to 0.01 MOI SARS CoV-2 virus by high content imaging Chlorocebus sabaeus -0.03 % Antiviral activity determined as inhibition of SARS-CoV-2 induced cytotoxicity of VERO-6 cells at 10 uM after 48 hours exposure to 0.01 MOI SARS CoV-2 virus by high content imaging Chlorocebus sabaeus 0.14 % Antiviral activity determined as inhibition of SARS-CoV-2 induced cytotoxicity of VERO-6 cells at 10 uM after 48 hours exposure to 0.01 MOI SARS CoV-2 virus by high content imaging Chlorocebus sabaeus -0.03 % Antiviral activity determined as inhibition of SARS-CoV-2 induced cytotoxicity of VERO-6 cells at 10 uM after 48 hours exposure to 0.01 MOI SARS CoV-2 virus by high content imaging Chlorocebus sabaeus -0.07 %

Related Entries

Cross References

Resources Reference
ChEBI 4910
ChEMBL CHEMBL681
DrugBank DB00292
DrugCentral 1109
FDA SRS Z22628B598
Human Metabolome Database HMDB0014437
Guide to Pharmacology 5463
KEGG C07522
PDB V8D
PubChem 667484
SureChEMBL SCHEMBL39487
ZINC ZINC000000001408